Alkermes (ALKS) Gross Profit (2010 - 2026)
Alkermes (ALKS) posted Gross Profit of $397.9 million for Q2 2026, up 16.6% from $341.2 million a year earlier and up 20.1% from the prior quarter.
Powered by 
Analysis
Alkermes (ALKS) Gross Profit (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Profit at Alkermes was $1.41 billion, up 10.0% year-over-year; for FY2025, it came in at $1.28 billion, down 2.5% from FY2024.
- Annual Gross Profit shows a five-year compound annual growth rate of 8.3% (FY2020 to FY2025).
- In prior years, Alkermes' Gross Profit was $1.31 billion in FY2024 (-7.0%), $1.41 billion in FY2023 (+57.8%), $893.73 million in FY2022 (-8.5%) and $976.43 million in FY2021 (+13.5%).
- The Q2 2026 figure stands as the highest quarterly Gross Profit since Q2 2023.
- On a year-over-year basis, Gross Profit increased in five of the last eight quarters, with growth averaging 6.7%.
- The strongest year-over-year quarter for Gross Profit in the past five years was Q2 2023, with growth of 154.4%; the weakest was Q2 2024, with a decline of 39.1%.
- According to Business Quant data, Gross Profit for the three prior quarters was $331.33 million (Q1 2026), $338.34 million (Q4 2025) and $342.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Alkermes | 6.73 Bn | 3.86 Bn | 397.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 397.90 Mn |
| Mar 31, 2026 | 331.33 Mn |
| Dec 31, 2025 | 338.34 Mn |
| Sep 30, 2025 | 342.59 Mn |
| Jun 30, 2025 | 341.20 Mn |
| Mar 31, 2025 | 257.31 Mn |
| Dec 31, 2024 | 367.87 Mn |
| Sep 30, 2024 | 315.04 Mn |
| Jun 30, 2024 | 337.66 Mn |
| Mar 31, 2024 | 291.73 Mn |
| Dec 31, 2023 | 307.35 Mn |
| Sep 30, 2023 | 319.44 Mn |
| Jun 30, 2023 | 554.15 Mn |
| Mar 31, 2023 | 229.43 Mn |
| Dec 31, 2022 | 250.75 Mn |
| Sep 30, 2022 | 201.73 Mn |
| Jun 30, 2022 | 217.86 Mn |
| Mar 31, 2022 | 223.39 Mn |
| Dec 31, 2021 | 270.85 Mn |
| Sep 30, 2021 | 244.58 Mn |
API Access
Alkermes Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();